Samuel Bates Martin, SVP and CFO: Celldex Therapeutics CLDX Sell · Filed 24/06/18

Trade details

Type: Insider sale
Amount: $608,232.24
Shares · price: 17,172 sh · $35.42 a share
Held after: 28,125 sh
Stock: Celldex Therapeutics CLDX
Person: Samuel Bates MartinSVP and CFO
Trade date: 24/06/14
Filed: 24/06/18
Days to filing: 4 days

Sold 37.9% of holdings

Share of holding sold: 37.9%

Celldex Therapeutics trades, last 26 weeks

What else happened in Celldex Therapeutics around then

Filed or reported within 30 days of the trade day · 24/05/15~24/07/14

Samuel Bates Martin's recent trades

Samuel Bates MartinSVP and CFO
SellCelldex Therapeutics
Sell
Celldex Therapeutics
CLDX
$1.2M
35,000 sh
$1.2M
Filed 24/06/03
Traded 24/05/30